Vurdering af reguleringsmæssige behov - liste
Vurdering af reguleringsmæssige behov - liste
The assessment of regulatory needs list includes substances for which an assessment either is under development or has been completed.
For each substance, the table shows the assessing authority (submitter), the concern, the status and the suggested follow-up action, and the date of the latest update to the list entry.
Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.
Regulatory Management Option Analysis (RMOA) are assessments of regulatory needs. Publication of RMOA was initiated in February 2013 with the start of the implementation of the SVHC Roadmap. In 2019, authorities and in particular ECHA have moved to address more groups of substances.
The responsibility for the content of an assessment of regulatory needs rests with the authority that developed it. It is possible that other authorities do not have the same view and may develop a further assessment of regulatory needs for the same (group of) substances. Assessment of regulatory needs and their conclusions are compiled based on available information and may change in light of new information or further assessment.
Last updated 19 april 2024. Database contains 4860 unique substances/entries.
287-477-0
|
85535-85-9
|
Germany
|
Carcinogenic Endocrine disruption Mutagenic Toxic for reproduction |
Concluded
|
Restriction
|
08-okt.-2020
|
Details | |
203-466-5
|
107-13-1
|
Germany
|
Mutagenic Other human toxicity Toxic for reproduction |
Concluded
|
Other legislation
|
23-sep.-2014
|
Details | |
205-265-8
|
136-85-6
|
Germany
|
To be defined |
Concluded
|
CLH SVHC |
20-dec.-2023
|
Details | |
202-679-0
|
98-54-4
|
Germany
|
Endocrine disruption |
Concluded
|
SVHC
|
07-mar.-2017
|
Details | |
209-544-5
|
584-84-9
|
Germany
|
Bioaccumulation Carcinogenic Mutagenic Persistence Toxic for reproduction |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
202-966-0
|
101-68-8
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
19-dec.-2016
|
Details | |
225-863-2
|
5124-30-1
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
09-jun.-2017
|
Details | |
233-593-1
|
10254-57-6
|
Germany
|
Bioaccumulation Persistence |
Under development
|
No suggestion yet
|
Details | ||
201-245-8
|
80-05-7
|
Germany
|
Aggregated tonnage Endocrine disruption Widespread use |
Concluded
|
SVHC
|
15-aug.-2017
|
Details | |
265-002-8
|
64665-53-8
|
Germany
|
To be defined |
Concluded
|
CLH SVHC |
20-dec.-2023
|
Details | |
223-861-6
|
4098-71-9
|
Germany
|
Carcinogenic Exposure Mutagenic Other human toxicity |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
202-112-7
|
91-97-4
|
Germany
|
Respiratory sensitiser |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
202-039-0
|
91-08-7
|
Germany
|
Respiratory sensitiser |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
219-470-5
|
2440-22-4
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
CLH
|
11-apr.-2022
|
Details | |
422-600-5
|
73936-91-1
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
11-apr.-2022
|
Details | |
253-037-1
|
36437-37-3
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
01-apr.-2015
|
Details | |
221-573-5
|
3147-75-9
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
11-apr.-2022
|
Details | |
274-570-6
|
70321-86-7
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
11-apr.-2022
|
Details | |
223-383-8
|
3864-99-1
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC
|
10-jul.-2015
|
Details | |
219-799-4
|
2536-05-2
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
239-139-9
|
15087-24-8
|
Germany
|
Endocrine disruption |
Concluded
|
SVHC
|
10-jul.-2015
|
Details | |
221-641-4
|
3173-72-6
|
Germany
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
204-661-8
|
123-91-1
|
Germany
|
Bioaccumulation Persistence |
Concluded
|
SVHC Restriction |
17-jun.-2020
|
Details | |
211-463-5
|
646-06-0
|
Germany
|
Toxic for reproduction |
Concluded
|
CLH
|
15-dec.-2022
|
Details | |
220-474-4
|
2778-42-9
|
Germany
|
Respiratory sensitiser Skin sensitiser |
Concluded
|
Restriction
|
23-sep.-2014
|
Details | |
253-242-6
|
36861-47-9
|
Germany
|
Endocrine disruption |
Concluded
|
SVHC
|
10-jul.-2015
|
Details | |
show/hide
|
799-976-5
|
-
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
SVHC
|
29-apr.-2019
|
Details |
204-112-2
|
115-86-6
|
France
|
Endocrine disruption Skin sensitiser |
Concluded
|
Other
|
10-sep.-2019
|
Details | |
202-924-1
|
101-20-2
|
France
|
Endocrine disruption |
Concluded
|
Other
|
09-aug.-2018
|
Details | |
201-067-0
|
77-90-7
|
France
|
Endocrine disruption |
Concluded
|
None
|
07-nov.-2016
|
Details | |
201-071-2
|
77-94-1
|
France
|
Endocrine disruption |
Concluded
|
Other legislation
|
30-sep.-2016
|
Details | |
260-830-6
|
57583-54-7
|
France
|
Endocrine disruption |
Concluded
|
Other
|
10-aug.-2018
|
Details | |
246-563-8
|
25013-16-5
|
France
|
Endocrine disruption |
Concluded
|
Restriction
|
30-jan.-2015
|
Details | |
216-653-1
|
1634-04-4
|
France
|
Concluded
|
CLH
|
14-dec.-2023
|
Details | ||
202-830-0
|
100-21-0
|
France
|
Endocrine disruption |
Concluded
|
None
|
07-mar.-2017
|
Details | |
-
|
-
|
France
|
Carcinogenic Mutagenic Other human toxicity Toxic for reproduction |
Concluded
|
Restriction
|
12-nov.-2019
|
Details | |
201-581-5
|
85-01-8
|
France
|
Bioaccumulation Other environmental toxicity Persistence |
Concluded
|
SVHC
|
13-okt.-2017
|
Details | |
205-391-3
|
140-01-2
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
CLH
|
01-apr.-2016
|
Details | |
247-421-8
|
26038-87-9
|
France
|
Endocrine disruption Other human toxicity Persistence |
Under development
|
No suggestion yet
|
Details | ||
228-250-8
|
6197-30-4
|
France
|
Bioaccumulation Endocrine disruption Other environmental toxicity Other human toxicity Persistence Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||
232-104-9
|
7786-81-4
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other legislation
|
02-feb.-2017
|
Details | |
234-323-5
|
11099-02-8
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
Other legislation
|
02-feb.-2017
|
Details | |
236-068-5
|
13138-45-9
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||
235-008-5
|
12054-48-7
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||
231-743-0
|
7718-54-9
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||
242-522-3
|
18718-11-1
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||
200-652-8
|
67-43-6
|
France
|
Carcinogenic Mutagenic Toxic for reproduction |
Concluded
|
CLH
|
01-apr.-2016
|
Details | |
203-615-4
|
108-78-1
|
France
|
Endocrine disruption |
Under development
|
No suggestion yet
|
Details | ||
215-183-4
|
1310-65-2
|
France
|
Endocrine disruption Other environmental toxicity Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||
231-212-3
|
7447-41-8
|
France
|
Endocrine disruption Other environmental toxicity Toxic for reproduction |
Under development
|
No suggestion yet
|
Details | ||